— Know what they know.
Not Investment Advice

ORGO NASDAQ

Organogenesis Holdings Inc.
1W: +2.7% 1M: +10.4% 3M: -33.3% YTD: -42.7% 1Y: -18.4% 3Y: -12.5% 5Y: -85.8%
$2.66
+0.00 (+0.00%)
 
Weekly Expected Move ±10.4%
$2 $2 $2 $3 $3
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Buy · Power 65 · $342.3M mcap · 57M float · 2.61% daily turnover · Short 56% of daily vol

📊 Key Metrics

TTM
$514M
Revenue
+12.0% YoY
$-0M
Net Income
+98.2% YoY
$17M
Free Cash Flow
+344.0% YoY
-2.5%
Gross Margin
-174.7%
Op. Margin
-150.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-0.1%
ROA-0.1%
ROIC-0.1%

Valuation

P/E-1197.0
P/B0.9
EV/EBITDA8.4

Leverage

Debt/Equity0.31
Current Ratio3.62
Interest Cov.28.3x

Quality Scores

Piotroski F5/9
Altman Z2.54
Beneish M-16.29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms